Senior writer Matthew Herper of STAT claims Marty Makary was the worst FDA commissioner in 25 years due to his lack of understanding and poor leadership.
Marty Makary served as FDA commissioner for just over a year. He resigned under pressure from the agency on Tuesday, according to reports. Senior writer Matthew Herper of STAT magazine has harsh criticism for Makary's tenure at the FDA, stating that he was the worst commissioner in 25 years without reservation.
Herper attributes Makary’s shortcomings to his fundamental lack of understanding about the role and functions of the FDA, as well as its employees. During his time in office, Makary allowed a significant number of senior leadership positions within the agency to vacate or be removed, which Herper argues weakened the agency's standards and disregarded those who understood both scientific principles and regulatory politics.
While Herper acknowledges that Makary made some positive efforts such as promoting AI in drug development, speeding up the review process, and accelerating clinical trials, these accomplishments were overshadowed by his overall poor leadership. Toward the end of his tenure, Makary seemed isolated and fixated on achieving "wins" that often had little substance.
Herper's critique is particularly damning given his long-standing coverage of the FDA over the past two decades. His perspective offers a rare insider’s view into the challenges faced by the agency under Makary's leadership. The resignation of such an important figure underscores the significant issues within the FDA and highlights the need for better management and understanding of regulatory roles.
As the agency moves forward, questions remain about how to address these shortcomings and ensure that future commissioners are better equipped to handle the complex responsibilities of overseeing drug safety and efficacy.
